
Evelo Biosciences Investor Relations Material
Latest events

Q4 2022
Evelo Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Evelo Biosciences Inc
Access all reports
Evelo Biosciences, Inc. (EVLO) is a clinical-stage biotechnology company engaged in the discovery and development of novel oral medicines. These medicines are designed to act on immune cells within the small intestine, with the aim of achieving systemic effects. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the OTC markets.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
EVLO
Country
🇺🇸 United States